(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OUTLOOK THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OUTLOOK THERAPEUTICS

ST13

US500000088201817

Class

42

Filing

88201817

Registration

6827946

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

0

Latest update

03/20/2025

Trademark type

Word

Nice classes

42

Filing date

11/20/2018

Registration date

08/23/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/23/2022

Last transaction

03/20/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/18/2018

First use in commerce

12/18/2018

Drawing code

4

Owner type

03

Owner location

Iselin, NJ

Examiner

BEAUDRY-TORRES, FAITH

Law office

N80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

OUTLOOK THERAPEUTICS, INC.
Oncobiologics, Inc.

Representatives

Kelley B. Harrington Cooley LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical research and development; provision of medical research and scientific research services and information in the field of pharmaceuticalsbiologicsbiosimilar drugsclinical trials

Publications

History of USPTO decisions and trademark events.

No publications found.

Continuous trademark protection

Get notified about every new filing that threatens OUTLOOK THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.